TrialJournal of the American Heart Association2018

Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials.

Antonio J Vallejo-Vaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.